IRAK1: A novel TOLLway to target ovarian cancer

被引：0
|
作者：
Standing, David [1 ]
Gunewardena, Sumedha [1 ]
Sayed, Afreen A. [1 ]
Pritchard, Michele T. [1 ]
Pathak, Harsh B. [1 ]
Godwin, Andrew K. [1 ]
Petersen, Shariska [1 ]
Khabele, Dineo [2 ]
Roy, Jensen A. [1 ]
Dandawate, Prasad [1 ]
Weir, Scott J. [1 ]
Anant, Shrikant [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[2] Siteman Canc Ctr, St Louis, MO USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5306
引用
收藏
页数：1
相关论文
共 50 条
  • [1] IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival
    Adams, Allie K.
    Bolanos, Lyndsey C.
    Dexheimer, Phillip J.
    Karns, Rebekah A.
    Aronow, Bruce J.
    Komurov, Kakajan
    Jegga, Anil G.
    Casper, Keith A.
    Patil, Yash J.
    Wilson, Keith M.
    Starczynowski, Daniel T.
    Wells, Susanne I.
    ONCOTARGET, 2015, 6 (41) : 43395 - 43407
  • [2] IRAK1, a potential therapeutic target for rheumatoid arthritis?
    Xie, Qiang
    Wang, Shi-Cun
    Li, Jun
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 3069 - 3070
  • [3] IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
    Zhen Ning Wee
    Siti Maryam J. M. Yatim
    Vera K Kohlbauer
    Min Feng
    Jian Yuan Goh
    Yi Bao
    Puay Leng Lee
    Songjing Zhang
    Pan Pan Wang
    Elgene Lim
    Wai Leong Tam
    Yu Cai
    Henrik J Ditzel
    Dave S. B. Hoon
    Ern Yu Tan
    Qiang Yu
    Nature Communications, 6
  • [4] IRAK1, a potential therapeutic target for rheumatoid arthritis?
    Qiang Xie
    Shi-Cun Wang
    Jun Li
    Rheumatology International, 2013, 33 : 3069 - 3070
  • [5] IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
    Wee, Zhen Ning
    Yatim, Siti Maryam J. M.
    Kohlbauer, Vera K.
    Feng, Min
    Goh, Jian Yuan
    Yi, Bao
    Lee, Puay Leng
    Zhang, Songjing
    Wang, Pan Pan
    Lim, Elgene
    Tam, Wai Leong
    Cai, Yu
    Ditzel, Henrik J.
    Hoon, Dave S. B.
    Tan, Ern Yu
    Yu, Qiang
    NATURE COMMUNICATIONS, 2015, 6
  • [6] Targeting Interleukin-1 Receptor-Associated Kinase 1 (IRAK1) In Ovarian Cancer
    Raval, Nipam
    Mohammadzadeh, Darya
    Nguyen, Teresa
    FASEB JOURNAL, 2021, 35
  • [7] Correction: Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
    Zhen Ning Wee
    Siti Maryam J. M. Yatim
    Vera K. Kohlabauer
    Min Feng
    Jian Yuan Goh
    Yi Bao
    Puay Leng Lee
    Songjing Zhang
    Pan Pan Wang
    Elgene Lim
    Wai Leong Tam
    Yu Cai
    Henrik J. Ditzel
    Dave S. B. Hoon
    Ern Yu Tan
    Qiang Yu
    Nature Communications, 6
  • [8] Crystal structure of human IRAK1
    Wang, Li
    Qiao, Qi
    Ferrao, Ryan
    Shen, Chen
    Hatcher, John M.
    Buhrlage, Sara J.
    Gray, Nathanael S.
    Wu, Hao
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (51) : 13507 - 13512
  • [9] IRAK1: oncotarget in MDS and AML
    Beverly, Levi J.
    Starczynowski, Daniel T.
    ONCOTARGET, 2014, 5 (07) : 1699 - 1700
  • [10] IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel (vol 6, 8746, 2015)
    Wee, Zhen Ning
    Maryam, Siti
    Yatim, J. M.
    Kohlabauer, Vera K.
    Feng, Min
    Goh, Jian Yuan
    Yi, Bao
    Lee, Puay Leng
    Zhang, Songjing
    Wang, Pan Pan
    Lim, Elgene
    Tam, Wai Leong
    Cai, Yu
    Ditzel, Henrik J.
    Hoon, Dave S. B.
    Tan, Ern Yu
    Yu, Qiang
    NATURE COMMUNICATIONS, 2015, 6
12345